Barnes PJ - Search Results

1

Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.

Yu LM, Bafadhel M, Dorward J, Hayward G, Saville BR, Gbinigie O, Van Hecke O, Ogburn E, Evans PH, Thomas NPB, Patel MG, Richards D, Berry N, Detry MA, Saunders C, Fitzgerald M, Harris V, Shanyinde M, de Lusignan S, Andersson MI, Barnes PJ, Russell REK, Nicolau DV Jr, Ramakrishnan S, Hobbs FDR, Butler CC; PRINCIPLE Trial Collaborative Group. Yu LM, et al. Among authors: barnes pj. Lancet. 2021 Sep 4;398(10303):843-855. doi: 10.1016/S0140-6736(21)01744-X. Epub 2021 Aug 10. Lancet. 2021. PMID: 34388395 Free PMC article. Clinical Trial.

2

A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma.

Evans DJ, Taylor DA, Zetterstrom O, Chung KF, O'Connor BJ, Barnes PJ. Evans DJ, et al. Among authors: barnes pj. N Engl J Med. 1997 Nov 13;337(20):1412-8. doi: 10.1056/NEJM199711133372002. N Engl J Med. 1997. PMID: 9358138 Free article. Clinical Trial.

3

Regular inhaled salbutamol and asthma control: the TRUST randomised trial. Therapy Working Group of the National Asthma Task Force and the MRC General Practice Research Framework.

Dennis SM, Sharp SJ, Vickers MR, Frost CD, Crompton GK, Barnes PJ, Lee TH. Dennis SM, et al. Among authors: barnes pj. Lancet. 2000 May 13;355(9216):1675-9. doi: 10.1016/s0140-6736(00)02238-8. Lancet. 2000. PMID: 10905242 Clinical Trial.

4

Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

Leckie MJ, ten Brinke A, Khan J, Diamant Z, O'Connor BJ, Walls CM, Mathur AK, Cowley HC, Chung KF, Djukanovic R, Hansel TT, Holgate ST, Sterk PJ, Barnes PJ. Leckie MJ, et al. Among authors: barnes pj. Lancet. 2000 Dec 23-30;356(9248):2144-8. doi: 10.1016/s0140-6736(00)03496-6. Lancet. 2000. PMID: 11191542 Clinical Trial.

5

Effects of recombinant human interleukin-12 on eosinophils, airway hyper-responsiveness, and the late asthmatic response.

Bryan SA, O'Connor BJ, Matti S, Leckie MJ, Kanabar V, Khan J, Warrington SJ, Renzetti L, Rames A, Bock JA, Boyce MJ, Hansel TT, Holgate ST, Barnes PJ. Bryan SA, et al. Among authors: barnes pj. Lancet. 2000 Dec 23-30;356(9248):2149-53. doi: 10.1016/S0140-6736(00)03497-8. Lancet. 2000. PMID: 11191543 Clinical Trial.

6

Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial.

Robinson DS, Campbell D, Barnes PJ. Robinson DS, et al. Among authors: barnes pj. Lancet. 2001 Jun 23;357(9273):2007-11. doi: 10.1016/S0140-6736(00)05113-8. Lancet. 2001. PMID: 11438132 Clinical Trial.

7

Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease.

Russell RE, Culpitt SV, DeMatos C, Donnelly L, Smith M, Wiggins J, Barnes PJ. Russell RE, et al. Among authors: barnes pj. Am J Respir Cell Mol Biol. 2002 May;26(5):602-9. doi: 10.1165/ajrcmb.26.5.4685. Am J Respir Cell Mol Biol. 2002. PMID: 11970913

8

Effect of theophylline on induced sputum inflammatory indices and neutrophil chemotaxis in chronic obstructive pulmonary disease.

Culpitt SV, de Matos C, Russell RE, Donnelly LE, Rogers DF, Barnes PJ. Culpitt SV, et al. Among authors: barnes pj. Am J Respir Crit Care Med. 2002 May 15;165(10):1371-6. doi: 10.1164/rccm.2105106. Am J Respir Crit Care Med. 2002. PMID: 12016098 Clinical Trial.

9

Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease.

Culpitt SV, Rogers DF, Shah P, De Matos C, Russell RE, Donnelly LE, Barnes PJ. Culpitt SV, et al. Among authors: barnes pj. Am J Respir Crit Care Med. 2003 Jan 1;167(1):24-31. doi: 10.1164/rccm.200204-298OC. Epub 2002 Sep 17. Am J Respir Crit Care Med. 2003. PMID: 12406856

10

Matrix metalloproteinase-9 expression in asthma: effect of asthma severity, allergen challenge, and inhaled corticosteroids.

Mattos W, Lim S, Russell R, Jatakanon A, Chung KF, Barnes PJ. Mattos W, et al. Among authors: barnes pj. Chest. 2002 Nov;122(5):1543-52. doi: 10.1378/chest.122.5.1543. Chest. 2002. PMID: 12426251

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,634 results

Search Page